🇺🇸 FDA
Patent

US 11826415

Method of conferring a protective immune response to Norovirus

granted A61KA61K2039/5258A61K2039/543

Quick answer

US patent 11826415 (Method of conferring a protective immune response to Norovirus) held by Takeda Vaccines, Inc. expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/5258, A61K2039/543, A61K2039/55572, A61K2039/55583